Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship

AK Dutta, A Jain, V Jearth, R Mahajan… - Indian Journal of …, 2023 - Springer
Proton pump inhibitors (PPIs) have been available for over three decades and are among
the most commonly prescribed medications. They are effective in treating a variety of gastric …

Time to benefit of bisphosphonate therapy for the prevention of fractures among postmenopausal women with osteoporosis: a meta-analysis of randomized clinical …

WJ Deardorff, I Cenzer, B Nguyen… - JAMA Internal …, 2022 - jamanetwork.com
Importance The clinical decision to initiate bisphosphonate therapy for the treatment of
osteoporosis requires balancing shorter-term harms and burdens (eg, gastroesophageal …

Safety issues and adverse reactions with osteoporosis management

M Rossini, G Adami, S Adami… - Expert opinion on drug …, 2016 - Taylor & Francis
Introduction: Osteoporosis is a disease that has spread worldwide and has become a
relevant public health problem. Over the last 2 decades, a number of drugs have been …

Predictors of long-term opioid use following lumbar fusion surgery

J Connolly III, Z Javed, MA Raji, W Chan, YF Kuo… - Spine, 2017 - journals.lww.com
Study Design. A population-based retrospective cohort study. Objective. The aim of this
study was to examine risk factors for long-term opioid use following lumbar spinal fusion …

Oral bisphosphonates are associated with increased risk of severe acute kidney injury in elderly patients with complex health needs: a self‐controlled case series in …

T Oda, AM Jödicke, DE Robinson… - Journal of Bone and …, 2020 - academic.oup.com
Although oral bisphosphonates (BP) are commonly used, there is conflicting evidence for
their safety in the elderly. Safety concerns might trump BP use in older patients with complex …

From pill to pain: Alendronate‐induced esophageal injury—A case report and review

Z Fan, H Khizar, J Lu, A Wang, T Xun, X Zhang… - JGH …, 2024 - Wiley Online Library
Background Alendronate is used to treat Paget's bone disease, glucocorticoid‐induced
osteoporosis, and postmenopausal osteoporosis because it suppresses osteoclast activity to …

Relationship between gastrointestinal events and compliance with osteoporosis therapy: an administrative claims analysis of the US managed care population

A Modi, S Sajjan, EM Lewiecki, ST Harris… - Clinical therapeutics, 2016 - Elsevier
Purpose A large proportion of women with osteoporosis do not comply with current
osteoporosis therapies, resulting in diminished therapeutic effect. Noncompliance may be …

Treatment with once‐weekly alendronate oral jelly compared with once‐weekly alendronate oral tablet for Japanese patients with primary osteoporosis: An open …

N Okimoto, Y Uemura, T Yoshioka, S Arita… - Health Science …, 2019 - Wiley Online Library
Background and aims Clinical data regarding alendronate jelly are limited. We compared
the efficacy and safety of once‐weekly alendronate oral jelly with once‐weekly alendronate …

Use and risk of side effects of antiresorptive medication in people with intellectual disabilities

V Frighi, M Smith, TA Holt - NIHR Open Research, 2022 - pmc.ncbi.nlm.nih.gov
Background: Recent studies show that adults with intellectual disabilities (ID) have high
incidence of major osteoporotic fracture, especially hip fracture. In those≥ 50 years, women …

Adverse drug effects involving the gastrointestinal system (pharmacist perspective)

P Goriacko, KT Veltri - Geriatric gastroenterology, 2021 - Springer
Advances in pharmacotherapy have greatly contributed to an increased life expectancy of
the adult population. As a result, an ever increasing proportion of the global population now …